Grant/GrossMendelsohn, LLC
- SEC CIK
- 0001810677
- Latest filing
- May 1, 2025
ABT holding history
Abbott Laboratories in every 13F filed by Grant/GrossMendelsohn, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q1 2025 holdings
- Shares (Q1 2025)
- 9,098
- Value
- $1.18M
- % of portfolio
- 0.7%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 9,098 | $1.18M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 9,098 | $1.03M | 0.5% | −403−4.2% | Reduced | Holders |
| Q3 2024 | 9,501 | $1.08M | 0.5% | −130−1.3% | Reduced | Holders |
| Q2 2024 | 9,631 | $1.00M | 0.5% | −18−0.2% | Reduced | Holders |
| Q1 2024 | 9,649 | $1.08M | 0.5% | −2,797−22.5% | Reduced | Holders |
| Q4 2023 | 12,446 | $1.39M | 0.6% | +388+3.2% | Added | Holders |
| Q3 2023 | 12,058 | $1.17M | 0.5% | +30.0% | Added | Holders |
| Q2 2023 | 12,055 | $1.30M | 0.5% | +1,012+9.2% | Added | Holders |
| Q1 2023 | 11,043 | $1.12M | 0.6% | −12−0.1% | Reduced | Holders |
| Q4 2022 | 11,055 | $1.24M | 0.6% | +20.0% | Added | Holders |
| Q3 2022 | 11,053 | $1.08M | 0.6% | +535+5.1% | Added | Holders |
| Q2 2022 | 10,518 | $1.14M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,518 | $1.26M | 0.6% | +550+5.5% | Added | Holders |
| Q4 2021 | 9,968 | $1.35M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 9,968 | $1.26M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2021 | 9,968 | $1.17M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2021 | 9,968 | $1.20M | 1.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.